Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and β-thalassemia major

Current problems and future directions of transfusion-induced alloimmunization: summary of an NHLBI working group

(2011) James C. Zimring et al.   TRANSFUSION

Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents

(2010) W. Bao et al.   BLOOD

HLA type and risk of alloimmunization in sickle cell disease

(2009) Carolyn Hoppe et al.   AMERICAN JOURNAL OF HEMATOLOGY

Regulatory T-cell status in red cell alloimmunized responder and nonresponder mice

(2009) W. Bao et al.   BLOOD

Transfusion management of patients with sickle cell disease: the continuing dilemma

(2009)   TRANSFUSION

Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders

(2008) J. M. Higgins et al.   BLOOD

Inflammation and oxidant-stress in  -thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial

(2008) P. B. Walter et al.   HAEMATOLOGICA

IL-21 and TGF-β are required for differentiation of human TH17 cells

(2008) Li Yang et al.   NATURE